The bioavailability study of Dapagliflozin
Phase 1 other active
Quick answer
The bioavailability study of Dapagliflozin for not applicable (submitted trial is a bioequivalence study is a Phase 1 program (other) at Laboratorios Tillomed Spain S.L.U with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Laboratorios Tillomed Spain S.L.U
- Indication
- not applicable (submitted trial is a bioequivalence study
- Phase
- Phase 1
- Modality
- other
- Status
- active